Shigella Test Kit Market

The shigella test kit consists of tests and kits used to detect the presence of shigella bacteria in a clinical setting. The bacterium, if present in human stool, causes the disease shigellosis in patients, which is characterized by diarrheal symptoms, such as watery stools and fever. It uses polymerase chain reaction (PCR) technology to amplify the target Deoxyribonucleic acid (DNA) sequence and produce a detectable signal, which is then read by a reader or analyzed by using a laboratory computer. It is a rapid, simple, and cost-effective method of testing for shigella. The test is also useful for identifying infections that are similar to shigellosis, including diarrheal illness and other infections which are caused by bacteria such as salmonella, campylobacter, E. coli, clostridium difficile, and others.

Market Dynamics:

The market is expected to grow at a strong pace over the forecast period. The market growth is driven by the increasing incidence of gastrointestinal infections and diseases. Rising demand for point of care (POC) testing for gastrointestinal disorders and cancers is also driving the market growth. Moreover, the increasing awareness about the benefits of shigella testing is again propelling the market growth. Furthermore, technologically advanced molecular diagnostics are further supporting the global shigella test kit market growth.

However, lower sensitivity of this kit as compared to the  lab test is expected to restrict the market growth of the global shigella test kit market.

Key features of the study:

• This report provides in-depth analysis of the global shigella test kit market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global shigella test kit market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global shigella test kit market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global shigella test kit market

Detailed Segmentation:

• Global Shigella Test Kit Market, By Test Type:
  • Lateral flow assays
  • Enzyme-linked immunosorbent assay (ELISA)
  • Polymerase chain reaction (PCR) assay
  • Others
• Global Shigella Test Kit Market, By Technology
  • Conventional diagnostic tests
  • Nucleic acid-based tests
  • Others
• Global Shigella Test Kit Market, By End Users
  • Hospitals
  • Diagnostic laboratories
  • Research institutes
  • Others
• Global Shigella Test Kit Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  
  • Thermo Fisher Scientific Inc.
  • Meridian Bioscience Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories Inc.
  • Creative Diagnostics
  • Hardy Diagnostics
  • Luminex Corporation
  • DiaSorin S.p.A.
  • Sekisui Diagnostics LLC
  • BioMérieux SA
  • MP Biomedicals LLC
  • Coris BioConcept
  • Alere Inc.
  • Fujirebio Diagnostics Inc.
  • CTK Biotech Inc.